Sickle cell anemia treated with stem cells


Know more about
Sickle cell anemia
Sickle cell anemia treated with stem cells

MIT researchers have successfully treated mice with sickle-cell anemia in a process that begins by directly reprogramming the mice's own cells to an embryonic-stem-cell-like state, without the use of eggs.

This is the first proof-of-principle of therapeutic application in mice of directly reprogrammed induced pluripotent stem (IPS) cells, which recently have been derived in mice as well as humans.

"This demonstrates that IPS cells have the same potential for therapy as embryonic stem cells, without the ethical and practical issues raised in creating embryonic stem cells," said MIT biology professor Rudolf Jaenisch, a member of the Whitehead Institute for Biomedical Research.

The research, reported Dec. 6 in Science online, was carried out in Jaenisch's laboratory. The IPS cells were derived using modifications of the approach originally discovered in 2006 by the Shinya Yamanaka laboratory at Kyoto University.

A disease of the blood marrow caused by a defect in a single gene, sickle-cell anemia is the most common inherited blood disorder in the United States, affecting more than 70,000 Americans and one in 500 African-Americans, according to the National Institutes of Health.

The scientists in Jaenisch's lab studied a therapeutic application of IPS cells with the sickle-cell anemia model mouse developed by the laboratory of Tim Townes of the University of Alabama at Birmingham. The mouse model had been designed to include relevant human genes involved in blood production, including the defective version of that gene.

This work was funded in part the National Institutes of Health.



(Editor compiled and published Sickle cell anemia treated with stem cells at HealthNewsTrack on December 9, 2007 sourced from Massachusetts Institute of Technology - http://web.mit.edu/newsoffice/2007/sickle-cell-1207.html)

Sickle cell anemia article/news source:

Read more health articles from Massachusetts Institute of Technology and health articles from USA.

Sickle cell anemia - search related terms:

Anemia, Biomedical, Embryonic stem cell, Gene, Health, Research, Sickle cell anemia, Stem cell, Therapeutic, Therapy,
Sickle cell anemia books,

Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.


Subscribe to Health News by Email

Current news
Using a new type of stem cells made from ordinary skin cells, US researchers said they treated mice with sickle cell anemia.

Sickle cell anemia
About Sickle cell anemia
Sickle cell anaemia is a chronic, usually fatal anemia marked by sickle-shaped red blood cells, occurring almost exclusively in Black people of Africa or of African descent, and characterized by episodic pain in the joints, fever, leg ulcers, and jaundice. The disease occurs in individuals who are homozygous for a mutant hemoglobin gene. Also called sickle cell disease.


List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
1.67